YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
6.34
+0.30 (4.97%)
Oct 28, 2026, 10:22 AM EDT - Market open
YD Bio Market Cap
YD Bio has a market cap or net worth of $449.07 million as of October 28, 2026. It is the 15,616th most valuable company in the world and the 2,852nd biggest in the United States. Its market cap has decreased by 62.68% in one year.
Market Cap
449.07M
Enterprise Value
446.41M
1-Year Change
-62.68%
Global Rank
Country Rank
#2,852 United States
Category
ChartMarket Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $449.07M, an increase of 202.70%. That is a compound annual growth rate of 20.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 449.07M | -47.61% |
| Dec 31, 2025 | 857.20M | 1,788.97% |
| Dec 26, 2024 | 45.38M | -4.31% |
| Dec 28, 2023 | 47.42M | -5.87% |
| Dec 30, 2022 | 50.38M | -66.30% |
| Dec 31, 2021 | 149.47M | 3.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MapLight Therapeutics | 454.05M |
| Prothena Corporation | 452.28M |
| Ovid Therapeutics | 441.37M |
| REGENXBIO | 435.69M |
| Rezolute | 431.13M |
| Allogene Therapeutics | 424.95M |
| AgomAb Therapeutics NV | 413.68M |
| Assembly Biosciences | 413.32M |